DSM sells Canadian factory to AstraZeneca |
|
|
|
Published
:
Mon, 04 Jun 2007 07:50 |
AMSTERDAM (Thomson Financial) - Royal DSM NV has sold a biologics manufacturing facility in Canada to AstraZeneca, the company said in a press statement.Financial details were not disclosed but DSM said the transaction will lead to a small book profit for the Dutch chemicals group.The 66,000 square foot facility will be used by AstraZeneca to manufacture antibody drug candidates for clinical trials, DSM said.Dave van Ginhoven, dave.vanginhoven@thomson.comdvg/jlw/dvg/sljCOPYRIGHTCopyright AFX News Limited 2007. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.
|
|
|
|